Skip to main content
    N

    Neuronetics Inc (STIM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.28
    +0.03 (+2.40%)

    Market Cap: $120.60M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Neuronetics Inc (STIM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Neuronetics (STIM) has a market cap of $120.60M and an enterprise value of $160.49M. Its share count is up 14.40% from a year earlier. Revenue grew 23.01% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 33.08% above the market cap, as debt exceeds cash.

    Market Cap$120.60M
    Enterprise Value$160.49M
    Latest price (Nov 17, 2026)$1.28

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.30% in the quarter ended Sep 30, 2026 and grew 59.50% a year over 2 years.

    Shares Outstanding77.00M
    Shares Change (YoY)+14.40%
    Shares Change (QoQ)+5.30%
    Share Count Growth (2Y CAGR)+59.50%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 5.3x. Its year-end P/S ranged from 0.3x to 4.3x from 2018 to 2025.

    P/S Ratio0.6x
    Forward P/S0.7x
    P/B Ratio5.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 35.68% over 52 weeks and trades 43.86% below its 50-day average.

    Beta (1Y)2.10
    52-Week Change-35.68%
    1-Month Change-32.98%
    3-Month Change-59.24%
    6-Month Change+8.47%
    5-Year Change-56.73%
    Total Return (1Y)-35.68%
    Total Return (3Y CAGR)-1.76%
    Total Return (5Y CAGR)-20.86%
    Return vs SPY (1Y)-25.94%
    Max Drawdown (1Y)-62.12%
    Max Drawdown (3Y)-87.33%
    Sharpe Ratio (1Y)-0.14
    Correlation with SPY (1Y)0.25
    50-Day Average$2.28
    200-Day Average$1.86
    52-Week Range$0.80 to $3.44
    RSI (14 Days)30.5
    Average Volume (20 Days)3.18M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.01x current liabilities, and total debt is 3.31x shareholder equity.

    Current Ratio2.01x
    Quick Ratio1.82x
    Debt / Equity3.31x
    Interest Coverage-1.45x

    Returns and Efficiency

    Return on invested capital is -13.33% over the last 12 months, against a 5-year average of -24.84%.

    Return on Equity (ROE)-122.97%
    Return on Assets (ROA)-17.43%
    Return on Invested Capital (ROIC)-13.33%
    Return on Capital Employed (ROCE)-12.95%
    ROA (5Y Average)-27.72%
    ROIC (5Y Average)-24.84%
    Asset Turnover1.15x
    Inventory Turnover15.09x
    Receivables Turnover10.51x
    Cash Conversion Cycle7 days

    Scores

    STIM has an Altman Z-Score of -3.38, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-3.38
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $159.76M over the last 12 months.

    Revenue$159.76M
    Revenue Growth (YoY)+23.01%
    Gross Profit$80.97M
    Operating Income-$15.00M
    Pretax Income-$23.01M
    Net Income-$23.01M
    EBITDA-$9.70M
    EBIT-$13.61M
    Reported EPS (TTM)-$0.32

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 14.18% of the $131.96M in total assets.

    Cash and Equivalents$22.11M
    Total Debt$62.00M
    Net Debt$39.90M
    Net Debt Per Share$0.52
    Working Capital$27.03M
    Shareholder Equity$18.71M
    Book Value Per Share$0.24
    Tangible Book Value-$21.97M
    Total Assets$131.96M
    Total Liabilities$109.56M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.30M of capital spending, operating cash flow left -$9.58M of free cash flow.

    Operating Cash Flow-$8.28M
    Capital Expenditures$1.30M
    Free Cash Flow-$9.58M
    FCF Per Share-$0.13
    Depreciation and Amortization$3.92M
    Share Repurchases$545.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -9.39%, against a 5-year average of -42.75%.

    Gross Margin50.68%
    Operating Margin-9.39%
    Pretax Margin-14.40%
    Net Margin-14.40%
    EBITDA Margin-6.07%
    EBIT Margin-8.52%
    FCF Margin-6.00%
    Gross Margin (5Y Average)69.69%
    Operating Margin (5Y Average)-42.75%
    Net Margin (5Y Average)-48.06%

    Growth

    Revenue grew 31.76% a year over 3 years.

    Revenue Growth (3Y CAGR)+31.76%
    Revenue Growth (5Y CAGR)+24.81%
    Book Value Per Share Growth (2Y CAGR)-47.41%

    Revenue and profit by year

    Dividends and Yields

    STIM does not pay a dividend. Its free cash flow yield is -9.72%.

    FCF Yield-9.72%
    Buyback Yield-8.15%

    Peer Position

    Against 12 similar companies, STIM has the 11th highest P/S.

    P/S Ratio0.6x vs 2.0x median
    ROIC-13.33% vs -41.53% median
    Revenue Growth (Trailing 4 Quarters, YoY)+23.01% vs +13.76% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 8.92% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+8.92%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About STIM

    What is STIM's market cap?

    Neuronetics has a market cap of $120.60M. Its enterprise value, which adds debt and subtracts cash, is $160.49M.

    How many shares of STIM are outstanding?

    Neuronetics has 77.00M shares outstanding. The count is up 14.40% from a year earlier.

    Does STIM pay a dividend?

    No. Neuronetics does not pay a dividend.

    How much debt does STIM have?

    Neuronetics has $62.00M of total debt and $22.11M of cash and equivalents, a net debt position of $39.90M.